Congrats to @sunilacharya13, @lab_rezvani & collaborators for publishing in Cancer Discovery how CD28 costimulation enhances CAR-NK cell function! CAR27 NK cells with CD28-based costimulation were ~3x more likely to exhibit serial killing. Learn more:
cellchorus.com/news/cancer-d…
Attending SITC 2024? Four abstracts from CellChorus and collaborators feature TIMING data! Join us to learn how dynamic single-cell analysis improves screening donors, enhancing ADCC, quantifying potency/viability, and more.
cellchorus.com/news/four-abs…@sitcancer
Want to learn how to apply TIMING™ for potency and viability analysis in process development? Meet with us at BioProcess International in Boston Sept 25th 26th.
Already registered? Book a meeting in the conference app:
lnkd.in/g3nu5HHS@BioProcessIntl@InformaConnect
Check out the latest articles @NatureCancer "Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling" doi.org/10.1038/s43018-024-0…
Looking forward to #TCDisrupt2023! Thank you to the @TechCrunch team for recognizing the power of the @CellChorus TIMING™ platform to advance immune-cell based therapies.
.@CellChorus is a perfect example of how #tech giants are embracing the marriage between #computation and #biology. It's exciting to see!
Congrats, team, on getting into the program!
CellChorus Wins Phase I National Science Foundation SBIR Grant. The award will support development of microscale arrays for single-cell analysis in the life sciences industry. ow.ly/mzc6104Mih9
The @NIH has awarded @CellChorus (YC S21) $2.3M to scale its visual AI technology that predicts cell response to life-saving immunotherapies, enabling scientists to create new medications faster, at lower cost, and with a higher success rate.
houston.innovationmap.com/ce…